Ever Source Wealth Advisors, LLC Beam Therapeutics Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 15 shares of BEAM stock, worth $386. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 156
90.38%
Holding current value
$386
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BEAM
# of Institutions
246Shares Held
95.7MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$258 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$250 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$228 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$197 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$122 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.81B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...